CG Oncology, Inc.

CGON · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $5.9B · 142 employees
40
SEC Filings
$59.23
Close 2026-06-01
142
Employees

Business Summary

4 Item 1A. Risk Factors 38 Item 1B. Unresolved Staff Comments 101 Item 1C. Cybersecurity 101 Item 2. Properties 102 Item 3. Legal Proceedings 102 Item 4. Mine Safety Disclosures 103 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 104 Item 6. [Reserved] 106 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 107 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 12...

Latest Stock Quote

CGON 2026-06-01 $59.23 O:$62 H:$62.29 L:$58.28 Vol:0.8M VWAP:$59.4156
origin leaf: d9f25fd0e4584552a6fc4177332a48678328092b9fffb5b90f270ffd02238bed

Next Earnings

Q2 FY2026 — expected 2026-09-07

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-272025-12-310001193125-26-079498EDGAR98K words
2025-03-282024-12-310000950170-25-046351EDGAR—
2024-03-262023-12-310000950170-24-036143EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001193125-25-283000EDGAR25K words
2025-08-082025-06-300000950170-25-105855EDGAR—
2025-05-132025-03-310000950170-25-069831EDGAR—
2024-11-122024-09-300000950170-24-124642EDGAR—
2024-08-082024-06-300000950170-24-093238EDGAR—
2024-05-092024-03-310000950170-24-056196EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-270001193125-26-079452EDGAR2K words
2026-01-130001193125-26-011855EDGAR—
2026-01-090001193125-26-008329EDGAR—
2025-11-260001193125-25-298160EDGAR—
2025-11-140001193125-25-283108EDGAR—
2025-11-140001193125-25-281672EDGAR—
2025-09-090001991792-25-000007EDGAR—
2025-09-050001991792-25-000004EDGAR—
2025-08-080000950170-25-105487EDGAR—
2025-07-110000950170-25-095296EDGAR—

40 total filings indexed. 21 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001991792
TickerCGON
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.cgoncology.com
Listed2024-01-25

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: e629d719fedb01fa7730e14077c0632757d5882ec155a73fcf8167313d3b2e46
parent: 0ca374a5173d97997f630268913225d0c33d022250ef554d7983a06cab7be24a
content hash: cdd356c361e816f18c039d4b40332674467b761cd3b05960221faa920994bf9e
signed: 2026-06-02T19:00:37.883Z
sources: 10 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf